A Treatment to Eliminate SARS-CoV-2 Replication in Human Airway Epithelial Cells Is Safe for Inhalation as an Aerosol in Healthy Human Subjects인간 기도 상피 세포에서 SARS-CoV-2 복제를 제거하는 치료법은 건강한 인간 대상에서 에어로졸로 흡입하기에 안전합니다Article Published on 2021-01-012022-08-31 Journal: Respiratory care [Category] SARS, 유전자 메커니즘, 치료법, 치료제, [키워드] Activation aerosol airway Airway inflammation airway pH. Cell cells clinical trial Concentration COVID-19 Defense determine Diseases endosomal trafficking expression had no healthy subjects Host host defense Human human airway epithelial humans impair in vivo Infection inhalation Inhaled inhibited isotonicity Lung function mechanisms multiplicity multiplicity of infection N protein no effect nucleocapsid osmolality Oxygenation Patient patient safety phase Placebo Plaque assay Prevent prevented protein levels raise raised Replication SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 viral replication subject subjects Treatment Trial USA-WA1/2020 viability Viral viral infection viral replication vital signs was determined [DOI] 10.4187/respcare.08425 PMC 바로가기 [Article Type] Article